Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Background/Aims: Aspirin has been demonstrated to possess potent chemopreventive and anticancer effects on prostate cancer. However, the more detailed molecular mechanisms of aspirin to suppress prostate cancer cell invasion have not been clearly elucidated. Methods: Transwell assays were performed...

Descripció completa

Dades bibliogràfiques
Autors principals: Chongjun Shi, Nini Zhang, Yang Feng, Jiewei Cao, Xuyi Chen, Bin Liu
Format: Article
Idioma:English
Publicat: Cell Physiol Biochem Press GmbH & Co KG 2017-03-01
Col·lecció:Cellular Physiology and Biochemistry
Matèries:
Invasion
Matrix metalloproteinase
Nuclear factor-kappa B
Prostate cancer
Urokinase-type plasminogen activator
Accés en línia:http://www.karger.com/Article/FullText/464434

Internet

http://www.karger.com/Article/FullText/464434

Ítems similars